Holistic Value Assessment of Tirbanibulin for Actinic Keratosis: European Multi-Criteria Decision Analysis

20260 citationsJournal Articlegold Open Access

Authors

Carola Berking · Friedrich-Alexander-Universität Erlangen-Nürnberg

Rafael Botella · Hospital Universitari i Politècnic La Fe

Andrea Carugno · University of Insubria

Giovanna Gambarelli

Josep Malvehy · Universitat de Barcelona

Elvira Moscarella · University of Campania "Luigi Vanvitelli"

Arianna Petracca

Gregorio Romero

Abstract

Overall, participants recognized tirbanibulin as a valuable treatment for AK, on the basis of robust evidence, favorable safety/tolerability and patient-reported outcomes (PRO) profiles, and alignment with clinical guidelines, with similar efficacy compared with 5FU-4%.

Topics & Keywords

Nonmelanoma Skin Cancer Studies Cutaneous Melanoma Detection and Management Head and Neck Cancer Studies

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: Dermatology and Therapy

Volume 16, Issue 4, pp. 2133-2152

DOI: 10.1007/s13555-026-01689-y

Field-Weighted Citation Impact: 0.00